Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Alise Carlson's publication output changed over time?
ScholarIQpublication output · 2021–2025
Output grew0% over the shown period — from 1 works in 2021 to 1 in 2025.
1
3
3
2
1
20212022202320242025
What are the most-cited papers on Alise Carlson?
ScholarIQmost cited works
Impacts of Climate Change and Air Pollution on Neurologic Health, Disease, and Practice
Shreya Louis, Alise Carlson, Abhilash Suresh, Joshua Rim, MaryAnn Mays, Daniel Ontaneda, Andrew Dhawan
Neurology. 2022134 CitationsOPEN ACCESS
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Alise Carlson, Moein Amin, Jeffrey A. Cohen
Drugs. 202473 CitationsOPEN ACCESS
Association of socioeconomic disadvantage and neighborhood disparities with clinical outcomes in multiple sclerosis patients
Justin Abbatemarco, Alise Carlson, Daniel Ontaneda, Marisa McGinley, Robert Bermel, Scott Husak, David Bruckman, Jesse D. Schold, Deborah Miller
S2764622253. 202221 Citations
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis
Nicole Bou Rjeily, Ellen M. Mowry, Daniel Ontaneda, Alise Carlson
Neurologic Clinics. 202319 Citations
Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis
Deja R Rose, Ahmad Mahadeen, Alise Carlson, Sarah M. Planchon, J Sedlák, Scott Husak, Robert A Bermel, Jeffrey A. Cohen, Brandon Moss
S4210234653. 202118 CitationsOPEN ACCESS
Related on ScholarIQ
Cleveland Clinic
Institution
Impacts of Climate Change and Air Pollution on Neurologic Health, Disease, and Practice
Paper
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Paper
Association of socioeconomic disadvantage and neighborhood disparities with clinical outcomes in multiple sclerosis patients
Paper
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis
Paper
Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis
Paper